Prognostic and clinicopathological significance of FOXD1 in various cancers: a meta and bioinformation analysis

References

• Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J. Clin. 72(1), 7–33 (2022).
   PubMed Web of Science ®Google Scholar
• Weigel D, Jürgens G, Küttner F, Seifert E, Jäckle H. The homeotic gene fork head encodes a nuclear protein and is expressed in the terminal regions of the Drosophila embryo. Cell 57(4), 645–658 (1989).
   PubMed Web of Science ®Google Scholar
• Lai E, Prezioso VR, Smith E, Litvin O, Costa RH, Darnell JE Jr. HNF-3A, a hepatocyte-enriched transcription factor of novel structure is regulated transcriptionally. Genes Develop. 4(8), 1427–1436 (1990).
   PubMed Web of Science ®Google Scholar
• Benayoun BA, Caburet S, Veitia RA. Forkhead transcription factors: key players in health and disease. Trends Genet. 27(6), 224–232 (2011).
   PubMed Web of Science ®Google Scholar
• Golson ML, Kaestner KH. Fox transcription factors: from development to disease. Development (Cambridge, England) 143(24), 4558–4570 (2016).
   PubMed Web of Science ®Google Scholar
• Hannenhalli S, Kaestner KH. The evolution of FOX genes and their role in development and disease. Nature reviews. Genetics. 10(4), 233–240 (2009).
   PubMed Web of Science ®Google Scholar
• Sackett SD, Li Z, Hurtt R et al. Foxl1 is a marker of bipotential hepatic progenitor cells in mice. Hepatology (Baltimore, Md.) 49(3), 920–929 (2009).
   PubMed Web of Science ®Google Scholar
• Aoki R, Shoshkes-Carmel M, Gao N et al. Foxl1-expressing mesenchymal cells constitute the intestinal stem cell niche. Cell. Mol. Gastroenterol. Hepatol. 2(2), 175–188 (2016).
   PubMedGoogle Scholar
• Zhu H. Forkhead box transcription factors in embryonic heart development and congenital heart disease. Life Sci. 144, 194–201 (2016).
   PubMed Web of Science ®Google Scholar
• Li CM, Gocheva V, Oudin MJ et al. Foxa2 and Cdx2 cooperate with Nkx2-1 to inhibit lung adenocarcinoma metastasis. Genes & Development 29(17), 1850–1862 (2015).
   PubMed Web of Science ®Google Scholar
• Otto FJ, Hettwer H. Flow cytometric discrimination of human semen cells. Cell. Mol. Biol. 36(2), 225–232 (1990).
   PubMed Web of Science ®Google Scholar
• Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur. J. Epidemiol. 25(9), 603–605 (2010).
   PubMed Web of Science ®Google Scholar
• Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat. Med. 17(24), 2815–2834 (1998).
   PubMed Web of Science ®Google Scholar
• Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8(1), 16 (2007).
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 7(3), 177–188 (1986).
   PubMedGoogle Scholar
• Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4), 1088–1101 (1994).
   PubMed Web of Science ®Google Scholar
• Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109), 629–634 (1997).
   PubMed Web of Science ®Google Scholar
• Zhao YF, Zhao JY, Yue H et al. FOXD1 promotes breast cancer proliferation and chemotherapeutic drug resistance by targeting p27. Biochem. Biophys. Res. Commun. 456(1), 232–237 (2015).
   PubMed Web of Science ®Google Scholar
• Nakayama S, Soejima K, Yasuda H et al. FOXD1 expression is associated with poor prognosis in non-small cell lung cancer. Anticancer Res. 35(1), 261–268 (2015).
   PubMed Web of Science ®Google Scholar
• Han T, Lin J, Wang Y et al. Forkhead box D1 promotes proliferation and suppresses apoptosis via regulating polo-like kinase 2 in colorectal cancer. Biomed. Pharmacother. 103, 1369–1375 (2018).
   PubMed Web of Science ®Google Scholar
• Li D, Fan S, Yu F et al. FOXD1 promotes cell growth and metastasis by activation of vimentin in NSCLC. Cell. Physiol. Biochem. 51(6), 2716–2731 (2018).
   PubMedGoogle Scholar
• Pan F, Li M, Chen W. FOXD1 predicts prognosis of colorectal cancer patients and promotes colorectal cancer progression via the ERK 1/2 pathway. Am. J. Translat. Res. 10(5), 1522–1530 (2018).
   PubMed Web of Science ®Google Scholar
• Zeyu J, Weicheng L, Zongze G, Peng C. The expression of FOXD1 in glioma tissue and its relationship with the prognosis of patients. J. Chinese J. Cancer Biother. 25(04), 351–356 (2018).
   Google Scholar
• Chang S, Sun L, Feng G. SP1-mediated long noncoding RNA POU3F3 accelerates the cervical cancer through miR-127-5p/FOXD1. Biomed. & Pharmacother. 117, doi: 10.1016/j.biopha.2019.109133 (2019).
   Web of Science ®Google Scholar
• Li Z, Yan T, Wu X et al. Increased expression of FOXD1 is associated with cervical node metastasis and unfavorable prognosis in oral squamous cell carcinoma. J. Oral Pathol. Med. 49(10), 1030–1036 (2020).
   PubMed Web of Science ®Google Scholar
• Qiu S, Li D, Shen Z et al. Diagnostic and prognostic value of FOXD1 expression in head and neck squamous cell carcinoma. J. Cancer 12(3), 693–702 (2021).
   PubMed Web of Science ®Google Scholar
• Fangmi D, Zhendong L. Forkhead box protein D1 activates extracellular signal-regulated kinase pathway to promote invasion and metastasis of pancreatic cancer. J. Surg. Theory Practice 25(06), 486–492 (2020).
   Google Scholar
• Li X, Yan G. The relationship between the expression of FOXD1 and the clinicopathological characteristics and cell biological behavior of patients with colon cancer. J. Colorect. Anal Surg. 26(01), 69–74 (2020).
   Google Scholar
• Chen S, Yang M, Wang C et al. Forkhead box D1 promotes EMT and chemoresistance by upregulating lncRNA CYTOR in oral squamous cell carcinoma. Cancer Lett. 503, 43–53 (2021).
   PubMed Web of Science ®Google Scholar
• Chen Y, Liang W, Liu K, Shang Z. FOXD1 promotes EMT and cell stemness of oral squamous cell carcinoma by transcriptional activation of SNAI2. Cell & Biosci. 11(1), 154 (2021).
   PubMed Web of Science ®Google Scholar
• Lin C, Yamin Z, Songlan Z, Yajie S. Expression level and clinical significance of forkhead box D1 in patients with epithelial ovarian cancer. J. Cancer Progress 19(13), 1329–1332 (2021).
   Google Scholar
• Junjie H, Bin L. Analysis of the expression and clinical significance of FOXD1 in oral squamous cell carcinoma based on TCGA and GEO databases. J. China Med. Univer. 50(11), 990–996 (2021).
   Google Scholar
• Wang Y, Qiu C, Lu N et al. FOXD1 is targeted by miR-30a-5p and miR-200a-5p and suppresses the proliferation of human ovarian carcinoma cells by promoting p21 expression in a p53-independent manner. Internat. J. Oncol. 52(6), 2130–2142 (2018).
   PubMed Web of Science ®Google Scholar
• Wang Z, Cheng Y, Zhu Y et al. Long non-coding RNA FOXD1-AS1 promotes the progression and glycolysis of nasopharyngeal carcinoma by sustaining FOXD1 expression. Am. J. Cancer Res. 10(11), 3686–3704 (2020).
   PubMed Web of Science ®Google Scholar
• Chen H, Lu Y, Cao Z et al. Cadmium induces NLRP3 inflammasome-dependent pyroptosis in vascular endothelial cells. Toxicol. Lett. 246, 7–16 (2016).
   PubMed Web of Science ®Google Scholar
• Zhang Y, Tian Q, Huang S et al. Prognostic effect of lncRNA SNHG7 on cancer outcome: a meta and bioinformatic analysis. BMC Cancer 22(1), 10 (2022).
   PubMedGoogle Scholar
• Levinson RS, Batourina E, Choi C, Vorontchikhina M, Kitajewski J, Mendelsohn CL. Foxd1-dependent signals control cellularity in the renal capsule, a structure required for normal renal development. Development (Cambridge, England) 132(3), 529–539 (2005).
   PubMed Web of Science ®Google Scholar
• Quintero-Ronderos P, Laissue P. The multisystemic functions of FOXD1 in development and disease. J. Mol. Med. 96(8), 725–739 (2018).
   PubMed Web of Science ®Google Scholar
• Cohen-Solal KA, Kaufman HL, Lasfar A. Transcription factors as critical players in melanoma invasiveness, drug resistance, and opportunities for therapeutic drug development. Pigment Cell Melanoma Res. 31(2), 241–252 (2018).
   PubMed Web of Science ®Google Scholar
• Huang J, Liang B, Wang T. FOXD1 expression in head and neck squamous carcinoma: a study based on TCGA, GEO and meta-analysis. Biosci. Rep. 41, BSR20210158 (2021).
   PubMed Web of Science ®Google Scholar
• Mu L, Zhang J, Wu Z, Huang J, Cui Y. FOXD1 Regulates the Sensitivity of Cetuximab by Regulating the Expression of EGFR in Head and Neck Squamous Cell Cancer. J. Healthcare Engin. 2022, doi: 10.1155/2022/6108241 (2022).
   Web of Science ®Google Scholar
• Lin CH, Lee HH, Chang WM et al. FOXD1 Repression Potentiates Radiation Effectiveness by Downregulating G3BP2 Expression and Promoting the Activation of TXNIP-Related Pathways in Oral Cancer. Cancers 12, 2690 (2020).
   PubMed Web of Science ®Google Scholar
• Fan L, Wang J, Deng P et al. Foxhead box D1 promotes the partial epithelial-to-mesenchymal transition of laryngeal squamous cell carcinoma cells via transcriptionally activating the expression of zinc finger protein 532. Bioengineered 13(2), 3057–3069 (2022).
   PubMed Web of Science ®Google Scholar
• Ou B, Zhao J, Guan S et al. Plk2 promotes tumor growth and inhibits apoptosis by targeting Fbxw7/Cyclin E in colorectal cancer. Cancer Lett. 380(2), 457–466 (2016).
   PubMed Web of Science ®Google Scholar
• Boza-Serrano A, Ruiz R, Sanchez-Varo R et al. Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer's disease. Acta Neuropathol. 138(2), 251–273 (2019).
   PubMed Web of Science ®Google Scholar
• Xie F, Li Y, Liang B. The Expression and Survival Significance of FOXD1 in Lung Squamous Cell Carcinoma: A Meta-Analysis, Immunohistochemistry Validation, and Bioinformatics Analysis. BioMed Res. Internat. 2022, doi: 10.1155/2022/7798654 (2022).
   Web of Science ®Google Scholar
• Long Y, Chong T, Lyu X et al. FOXD1-dependent RalA-ANXA2-Src complex promotes CTC formation in breast cancer. J. Experimen. Clinic. Cancer Res. 41(1), 301 (2022).
   PubMed Web of Science ®Google Scholar
• Cai K, Chen S, Zhu C et al. FOXD1 facilitates pancreatic cancer cell proliferation, invasion, and metastasis by regulating GLUT1-mediated aerobic glycolysis. Cell Death Dis. 13(9), 765 (2022).
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang W. FOXD1, negatively regulated by miR-186, promotes the proliferation, metastasis and radioresistance of nasopharyngeal carcinoma cells. Cancer Biomark. 28(4), 511–521 (2020).
   PubMed Web of Science ®Google Scholar